33.52% of Achieve Life Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Achieve Life Sciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/2/2024	Madison Park Capital Advisors LLC	10,000	$41K	0.0%	N/A	0.047%
1/16/2024	Raymond James & Associates	154,829	$0.64M	0.0%	+6.0%	0.731%
11/6/2023	Manchester Financial Inc.	18,600	$80K	0.0%	+43.9%	0.088%
10/24/2023	Raymond James & Associates	146,100	$0.63M	0.0%	+6.3%	0.692%
8/14/2023	Shay Capital LLC	776,600	$4.03M	0.6%	+61.8%	4.305%
8/14/2023	One68 Global Capital LLC	96,700	$0.50M	3.1%	N/A	0.536%
8/14/2023	Prelude Capital Management LLC	26,992	$0.14M	0.0%	+77.3%	0.150%
8/11/2023	AWM Investment Company Inc.	272,500	$1.41M	0.2%	N/A	1.511%
7/31/2023	LPL Financial LLC	148,000	$0.77M	0.0%	+2.8%	0.820%
7/28/2023	Manchester Financial Inc.	12,925	$67K	0.0%	N/A	0.072%
7/27/2023	B. Riley Wealth Advisors Inc.	216,216	$1.12M	0.0%	N/A	1.199%
7/25/2023	Raymond James & Associates	137,485	$0.71M	0.0%	+31.8%	0.762%
7/24/2023	BerganKDV Wealth Management LLC	5,000	$26K	0.0%	N/A	0.028%
7/21/2023	Perkins Capital Management Inc.	126,212	$0.66M	0.6%	-8.0%	0.700%
6/1/2023	Prelude Capital Management LLC	15,220	$0.10M	0.0%	+28.5%	0.084%
5/12/2023	Long Focus Capital Management LLC	140,220	$0.95M	0.1%	-55.2%	0.782%
5/9/2023	Perkins Capital Management Inc.	137,212	$0.93M	0.9%	-37.1%	0.765%
5/8/2023	Beaumont Financial Advisors LLC	12,000	$82K	0.0%	N/A	0.067%
4/14/2023	Raymond James & Associates	104,282	$0.71M	0.0%	+16.8%	0.582%
3/29/2023	Diametric Capital LP	19,903	$49K	0.0%	-42.6%	0.111%
11/15/2022	Long Focus Capital Management LLC	308,220	$1.02M	0.1%	+73.6%	3.184%
10/25/2022	Raymond James & Associates	17,431	$58K	0.0%	+34.6%	0.180%
10/24/2022	Perkins Capital Management Inc.	218,100	$0.72M	0.8%	-4.4%	2.253%
8/5/2022	Granite Point Capital Management L.P.	13,631	$67K	0.0%	N/A	0.141%
7/29/2022	Perkins Capital Management Inc.	228,100	$1.11M	1.2%	+30.6%	2.356%
5/17/2022	Shay Capital LLC	401,368	$3.04M	0.4%	-1.1%	4.146%
5/16/2022	Clearline Capital LP	120,094	$0.91M	0.1%	-1.6%	1.267%
5/13/2022	DLD Asset Management LP	45,528	$0.35M	0.0%	N/A	0.480%
2/15/2022	Shay Capital LLC	405,717	$3.16M	0.5%	+6.7%	4.292%
2/14/2022	Long Focus Capital Management LLC	60,000	$0.47M	0.1%	N/A	0.635%
2/10/2022	Paradigm Financial Partners LLC	35,250	$0.29M	0.0%	+198.7%	0.373%
2/10/2022	Perkins Capital Management Inc.	174,600	$1.36M	0.9%	+2.9%	1.847%
11/15/2021	Franklin Resources Inc.	34,050	$0.29M	0.0%	N/A	0.360%
11/15/2021	GSA Capital Partners LLP	38,491	$0.33M	0.0%	N/A	0.407%
11/12/2021	Oppenheimer & Co. Inc.	25,000	$0.21M	0.0%	+8.7%	0.264%
11/5/2021	Advisory Services Network LLC	13,000	$0.11M	0.0%	N/A	0.138%
10/25/2021	Perkins Capital Management Inc.	169,600	$1.44M	0.9%	-1.5%	1.794%
8/17/2021	Walleye Capital LLC	27,307	$0.25M	0.0%	N/A	0.443%
8/17/2021	Millennium Management LLC	101,986	$0.92M	0.0%	N/A	1.655%
8/17/2021	683 Capital Management LLC	125,000	$1.12M	0.0%	N/A	2.028%
8/16/2021	Occudo Quantitative Strategies LP	19,082	$0.17M	0.0%	N/A	0.310%
8/16/2021	Royal Bank of Canada	30,700	$0.28M	0.0%	N/A	0.498%
8/16/2021	State Street Corp	14,761	$0.13M	0.0%	N/A	0.239%
8/16/2021	Shay Capital LLC	403,075	$3.62M	0.4%	+198.6%	6.539%
8/13/2021	Renaissance Technologies LLC	76,960	$0.69M	0.0%	+248.9%	1.249%
8/13/2021	Northern Trust Corp	17,096	$0.15M	0.0%	N/A	0.277%
8/13/2021	Altium Capital Management LP	122,000	$1.10M	0.3%	N/A	1.979%
8/13/2021	QS Investors LLC	34,050	$0.31M	0.0%	N/A	0.552%
8/13/2021	LPL Financial LLC	68,800	$0.62M	0.0%	+30.1%	1.116%
8/13/2021	Geode Capital Management LLC	56,669	$0.51M	0.0%	+93.5%	0.919%
8/13/2021	Vanguard Group Inc.	248,882	$2.24M	0.0%	-15.9%	4.038%
8/12/2021	Dimensional Fund Advisors LP	27,493	$0.25M	0.0%	N/A	0.446%
8/3/2021	Oppenheimer & Co. Inc.	23,000	$0.21M	0.0%	N/A	0.373%
5/21/2021	Citadel Advisors LLC	12,456	$0.14M	0.0%	N/A	0.202%
5/18/2021	Morgan Stanley	87,546	$1.01M	0.0%	+8,754,500.0%	1.420%
5/18/2021	Citadel Advisors LLC	12,456	$0.14M	0.0%	N/A	0.203%
5/14/2021	Paradigm Financial Partners LLC	11,100	$0.13M	0.0%	N/A	0.180%
5/13/2021	Renaissance Technologies LLC	22,061	$0.26M	0.0%	N/A	0.359%
5/12/2021	Geode Capital Management LLC	29,290	$0.34M	0.0%	N/A	0.476%
3/26/2021	Susquehanna International Group LLP	10,510	$85K	0.0%	N/A	0.171%
2/9/2021	Perkins Capital Management Inc.	40,600	$0.33M	0.2%	N/A	1.122%
2/4/2021	GSA Capital Partners LLP	10,129	$82K	0.0%	-59.5%	0.280%
11/16/2020	Squarepoint Ops LLC	10,093	$84K	0.0%	N/A	0.281%
11/16/2020	Boothbay Fund Management LLC	33,389	$0.28M	0.0%	N/A	0.931%
11/13/2020	Morgan Stanley	15,919	$0.13M	0.0%	+72,259.1%	0.444%
11/6/2020	GSA Capital Partners LLP	24,990	$0.21M	0.0%	N/A	0.697%
11/6/2020	Hayden Royal LLC	13,420	$0.11M	0.1%	N/A	0.374%
8/14/2020	Ikarian Capital LLC	3,658,537	$1.45M	0.1%	N/A	233.325%
8/13/2020	Requisite Capital Management LLC	1,000,000	$0.40M	0.2%	N/A	63.776%
7/31/2020	UBS Group AG	91,946	$37K	0.0%	+17.0%	0.293%
5/1/2020	UBS Group AG	78,595	$26K	0.0%	+413.2%	0.251%

Data available starting January 2016

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc. is based in Vancouver, Canada.

Today's Range

Now: $4.55

$4.48

$4.64

50 Day Range

MA: $4.42

$3.82

$4.67

52 Week Range

Now: $4.55

$3.03

$10.30

Volume

16,090 shs

Average Volume

85,701 shs

Market Capitalization

$155.84 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.32

Who are the company insiders with the largest holdings of Achieve Life Sciences?: Achieve Life Sciences' top insider investors include:
John Bencich (CEO)
Learn More about top insider investors at Achieve Life Sciences.